Literature DB >> 176968

Electron microscope observations on tubular structures in cells infected with herpes simplex virus type 2.

H Oda, R Mori.   

Abstract

The fine structure of filamentous structures and lattice-like structures found in herpes simplex virus type 2-infected cells was studied. By specimen tilting experiments, it was demonstrated that the lattice-like structures were the cross-sectional views of the tubular structures and the filamentous structures were the longitudinal sections. The observation in negatively stained preparations of isolated tubular structures revealed that the structure was constructed by regular array of ring shaped elements. A hypothetical model is presented for tubular structures constructed on the basis of the present findings. The tubular structures appeared as early as 6 hours after infection and reached a maximum at 12 hours.

Entities:  

Mesh:

Year:  1976        PMID: 176968     DOI: 10.1007/bf01318010

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  Cytochemical studies. V. On the isolation and biochemical properties of liver cell nuclei.

Authors:  G H HOGEBOOM; W C SCHNEIDER; M J STRIEBICH
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

2.  Similarities and Differences in the Development of Laboratory Strains and Freshly Isolated Strains of Herpes Simplex Virus in HEp-2 Cells: Electron Microscopy.

Authors:  J Schwartz; B Roizman
Journal:  J Virol       Date:  1969-12       Impact factor: 5.103

3.  [Recurrent neonatal herpetic infection: isolation of Herpes simplex virus type 2].

Authors:  T Tasaki; R Mori; Y Minamishima; H Oda
Journal:  Z Hautkr       Date:  1975-01-15

4.  Hexagonal arrangement of filaments in herpes simplex virus type 2-infected cells.

Authors:  R Mori; Y Minamishima; T Tasaki; H Oda; A Takade
Journal:  Jpn J Microbiol       Date:  1973-05

5.  Characterization of genital strains of Herpesvirus hominis.

Authors:  I W Smith; J F Peutherer; D H Robertson
Journal:  Br J Vener Dis       Date:  1973-08

6.  Filamentous structures of type 2 Herpesvirus hominis infection of the chorioallantoic membrane.

Authors:  E F Couch; A J Nahmias
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

7.  Intranuclear formation of filaments in herpesvirus hominis infection of mice.

Authors:  F A Murphy; A K Harrison; S G Whitfield
Journal:  Arch Gesamte Virusforsch       Date:  1967

8.  Herpesvirus type 2 isolated from cervical tumor cells grown in tissue culture.

Authors:  L Aurelian; J D Strandberg; L V Melendez; L A Johnson
Journal:  Science       Date:  1971-11-12       Impact factor: 47.728

  8 in total
  6 in total

1.  Effects of antimetabolites on the production of tubular structures in Vero cells infected with herpes simplex virus type 2.

Authors:  H Oda; R Mori; J Miyazono; T Iwasaka
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  In Vitro Replication of Chelonid Herpesvirus 5 in Organotypic Skin Cultures from Hawaiian Green Turtles (Chelonia mydas).

Authors:  Thierry M Work; Julie Dagenais; Tina M Weatherby; George H Balazs; Mathias Ackermann
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Filamentous structures associated with Epstein-Barr virus-infected cells.

Authors:  C L Moore; J D Griffith; J E Shaw
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

4.  Herpes simplex virus (HSV) infection of organotypic nerve cell cultures. Tubule-like structures in the nuclei of cells infected with type 2 but not with type 1 virus.

Authors:  M S Ecob-Johnston; W O Whetsell
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

5.  Two cases of necrotizing myelopathy associated with malignancy caused by herpes simplex virus type 2.

Authors:  T Iwamasa; Y Utsumi; H Sakuda; H Yoshitake; T Kakazu; R Kubota; M Nakagawa
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine.

Authors:  H Irie; Y Harada; M Kataoka; M Nagamuta; Y Moriya; M Handa; M Saito; S Matsubara; K Kojima; Y Sugawara
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.